Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
48 participants
OBSERVATIONAL
2020-01-13
2025-01-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Social Cognition in Huntington's Disease: Cognitive Study and Functional and Morphological Imaging
NCT02550275
Functional Imaging of Social Cognition in Premanifest Huntington's Disease
NCT02551705
Assessment of the Psychological, Cognitive and Social Resources of Applicants for Huntington's Disease and Presymptomatic Genetic Testing
NCT02134561
Huntington's Disease Young Adult Study 2.0
NCT06391619
Characterization and Quantification of Motor Speech Disorders in Huntington's Disease: Identification of Acoustic Markers
NCT04630574
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* HD, CAG \> 36, motor UHDRS \> 5
* Being able to communicate with the investigator
For both spouses :
* Living together since at least 5 years
* 30 to 60 years old
Exclusion Criteria
\- Other chronic neurologic disorder
For both spouses :
* Psychiatric disease
* Unable to participate, incl read, understand and sign the informed consent
30 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clémence Simonin, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Lille
Pascal ANTOINE, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Roger Salengro, CHU Lille
Lille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A02046-49
Identifier Type: OTHER
Identifier Source: secondary_id
2018_33
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.